$SNSE

BTIG Research Initiates Coverage on Sensei Biotherapeutics With Buy Rating, $55 Price Target

Sensei Biotherapeutics (SNSE) has an average rating of Buy and mean price target of $51.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Cantor Fitzgerald Initiates Sensei Biotherapeutics at Overweight

Leerink Partners Initiates Coverage on Sensei Biotherapeutics With Outperform Rating, $50 PT

Sensei Biotherapeutics (SNSE) has an average rating of Buy and mean price target of $50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)